HIV positivity may not have a negative impact on survival in Epstein‑Barr virus‑positive Hodgkin lymphoma: A Japanese nationwide retrospective survey

DOI PubMed 参考文献27件オープンアクセス

Mihoko Yotsumoto

Department of Laboratory Medicine, Tokyo Medical University Hospital, Shinjuku‑ku, Tokyo 160‑0023, Japan
Yoshikazu Ito

Department of Hematology, Tokyo Medical University Hospital, Shinjuku‑ku, Tokyo 160‑0023, Japan
Shotaro Hagiwara

Department of Hematology, Tokyo Women's Medical University Hospital, Shinjuku‑ku, Tokyo 162‑8666, Japan
Yasuhito Terui

Department of Hematology Oncology, Cancer Institute Hospital of JFCR, Koto‑ku, Tokyo 135‑8550, Japan
Hirokazu Nagai

Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya‑shi, Aichi 460‑0001, Japan
Yasunori Ota

Department of Pathology, Teikyo University Hospital, Minato‑ku, Tokyo 173‑0003, Japan
Atsushi Ajisawa

Department of Infectious Diseases, Tokyo Metropolitan Toshima Hospital, Itabashi‑ku, Tokyo 173‑0015, Japan
Tomoko Uehira

Department of Infectious Diseases, National Hospital Organization Osaka National Hospital, Chuo‑ku, Osaka 540‑0006, Japan
Junko Tanuma

AIDS Clinical Center, National Center for Global Health and Medicine, Shinjuku‑ku, Tokyo 162‑8655, Japan
Kazuma Ohyashiki

Department of Hematology, Tokyo Medical University Hospital, Shinjuku‑ku, Tokyo 160‑0023, Japan
Seiji Okada

Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Chuo‑ku, Kumamoto 860‑8556, Japan

書誌事項

DOI

There has been no comparative clinical study focused on differences in the clinical features of Epstein-Barr virus (EBV)